Trainee Track Webinar
Getting Your Research Published in High Impact Journals
Thursday, April 13, 2017, 11am EST (Montreal time)
To view the recording of the presentation click here (You must be logged into the website)
Allan D. Kirk, MD, PhD
Professor of Surgery, Professor in the Department of Immunology, Professor in Pediatrics
Chair, Department of Surgery
Duke University School of Medicine
Durham, NC, United States
Robert L. Fairchild, PhD
Professor of Molecular Medicine
Cleveland Clinic Lerner College of Medicine
Professor of Pathology
Case Western Reserve University School of Medicine
Cleveland, Ohio, United States
This Webinar will provide an overview of medical publishing, particularly as it relates to transplantation. It will provide detail regarding the peer review process, introduce strategies for successfully navigating peer review and help demystify the process of journal review and publication.
Allan D. Kirk - Biography:
Allan D. Kirk is a native of Virginia Beach. He graduated from ODU in 1983, designated the Most Outstanding Senior in Biology, with a BS in Biology, summa cum laude. Thereafter, he received an MD and a PhD in Immunology from Duke University, where he also completed his surgery residency. He completed an organ transplant fellowship at the University of Wisconsin. Dr. Kirk served in the US Navy as a transplant surgeon and Chief of Transplant Research for the Armed Services Transplant Service in Washington, DC. During this time, he helped develop a new approach to preventing organ transplant rejection, known as costimulation blockade, and transitioned to the National Institutes of Health to develop this field further as Chief of their Transplantation Branch. In 2007, he moved to Emory University, as Vice Chair for Surgical Research, and in 2014, was appointed Chairman of the Department of Surgery at Duke University. He holds Professorships in Surgery, Pediatrics and Immunology and serves as Surgeon-in-Chief for the Duke University Health System. He has published >300 scientific manuscripts, and continues NIH- and FDA-sponsored investigations in organ transplantation, and DoD-sponsored work in limb replacement following combat amputation and immune management of catastrophic injury.
Robert L. Fairchild - Biography:
Robert L. Fairchild received a doctorate in immunology at the University of Missouri-Columbia and completed a postdoctoral fellowship at the University of Colorado Health Sciences Center and the National Jewish Hospital for Allergy and Immunology in Denver. He is currently a Professor of Molecular Medicine in the Cleveland Clinic Lerner College of Medicine and Professor in the Department of Pathology at Case Western Reserve University School of Medicine in Cleveland, Ohio.
Dr. Fairchild has served terms as a member on 3 NIH study sections and is a former Chair of the Tumors, Transplantation, and Tolerance (TTT) study section. He is currently a Deputy Editor for both the American Journal of Transplantation and for the Journal of Immunology.
Dr. Fairchild is principal investigator on NIH-funded studies focused on the impact of endogenous CD8 memory T cell activity on allograft outcome and on mechanisms underlying antibody mediated rejection of renal allografts using mouse models as well as clinical samples. Dr. Fairchild is a member of the Clinical Trials for Organ Transplantation Consortium and Director of the Molecular Core for CTOT-19.